The Countdown to #VitafoodsEurope2026 is On! 🍎💊 We are excited to announce that Sequentia Biotech will be attending @/Vitafoods Europe, the continent’s flagship nutraceutical event from May 5–7. As the industry gathers to explore the entire food supply chain, we are looking forward to discussing the evolving role of our technology in food safety, quality, and innovation. Our team—Walter Sanseverino (CEO), Riccardo Aiese Cigliano (CSO), and Maria Riba (Business Developer)—will be on the ground to stay up to date on the latest sector trends. In an era where transparency is non-negotiable, omics is becoming an essential tool for ensuring food safety, verifying ingredient authenticity, and developing next-generation food products. We also have a portfolio of no-code omics solutions that turn raw sequencing data into clear, actionable insights for safety and regulatory decisions, helping food, nutrition, and Food TIC (Testing, Inspection, and Certification) companies move from raw data to a competitive market edge. If you’re heading to Barcelona, let's connect and explore how a molecular approach can drive the next wave of food science! #VitafoodsEurope #FoodScience #SequentiaBiotech #FoodSafety #Nutraceuticals #Innovation #Omics #Bioinformatics
About us
Sequentia Biotech, an innovative bioinformatics firm, has been at the forefront of genomics since its establishment in 2013. Renowned for its cutting-edge solutions, Sequentia excels in providing comprehensive bioinformatics and software solutions across a spectrum of fields, including diagnostics, drug discovery, medical and academic research, plant biology, and food technologies. With a remarkable 15 years of experience in bioinformatics and significant investments in Research and Development (R&D), Sequentia has successfully completed over 700 bioinformatics projects. Serving clients in 63 countries, the company has contributed to over 70 publications in esteemed journals, showcasing an impressive H-index of 130. This outstanding track record underscores Sequentia's commitment to excellence. The company's overarching vision is to foster innovation and introduce disruptive technologies in the biotechnology landscape. By leveraging the potential of omics sciences, Sequentia aims to make meaningful contributions to society. Partner with Sequentia as they strive to shape a future where global advancements in biotechnology have a positive and transformative impact on lives.
- Website
-
http://www.sequentiabiotech.com
External link for Sequentia Biotech
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- Barcelona, Catalonia
- Type
- Privately Held
- Founded
- 2013
- Specialties
- Biotechnology, Bioinformatics, Genetics, Molecular Biology, R&D, Plant Science, Genomics, Transcriptomics, Epigenetics, Scientific Consulting, DNA-protein Interactions, Microbiomics, metagenomics, and bioinformatics softwares
Locations
-
Primary
Get directions
Carrer de Dr. Trueta 179
Barcelona, Catalonia 08005, ES
Employees at Sequentia Biotech
Updates
-
Sequentia Biotech reposted this
🔝 What made headlines this April in the #BioRegion of Catalonia? A month of clinical breakthroughs, major infrastructure milestones, and strategic funding to accelerate the future of healthcare. 📌 At a glance: ✔️ Vall d'Hebron Barcelona Hospital Campus and Hospital del Mar have launched a clinical trial of a new CAR-T therapy for breast cancer, developed by Banc de Sang i Teixits in Barcelona. ✔️ Methinks AI Software raises €2.19M to boost AI-driven early detection of neurological pathologies. ✔️ Sequentia Biotech secures CE-IVD marking for its MICK Clinical™ software under the new European IVDR regulation. ✔️ PRECISEU launches an €11.57M call for personalized medicine projects to support solutions with TRL 6 to TRL 8 maturity. ✔️ Ysios Capital participates in a major sector deal: the acquisition of Neurona Therapeutics by UCB, valued at up to $1.15B. ✔️ Construction begins on the new PRBB (Barcelona Biomedical Research Park) in the Ciutadella, a long-awaited step to expand the city’s scientific capacity. ✔️ Five Catalan centers set a precedent in efficiency and equitable access through the joint purchase of surgical robots. ✔️ Grifols receives FDA approval for its blood screening test for malaria. ✔️ d·HEALTH Barcelona, a Biocat program, opens applications for its 11th edition to train the next generation of health innovators. ✔️ Miquel Pons replaces Manel del Castillo Rey as the new manager of Hospital Sant Joan de Déu Barcelona. 💡 Curious to explore more? Read the full Picks of April 👉https://lnkd.in/eAZAGSeU
-
🧬 Beyond the Double Helix: Celebrating the Omics Revolution this #WorldDNADay On April 25th, we celebrate DNA—but today, we go far beyond it. We’re no longer just reading the code of life. We’re decoding entire biological systems through genomics and metagenomics. At Sequentia Biotech, we turn complex biological data into real-world impact across sectors: 🏥 Human Health → gastrointestinal diagnostics support (MICK CLINICAL™) 🌍 Public Health → advanced TB surveillance (MICK-MAGMA™) 🔬 R&D → advancing microbiome-driven research and innovation (GAIA™) 🛡️ Food Safety → rapid bacterial genomics for outbreak source tracking and prevention (PROKY™) The omics revolution is here—and it’s transforming how we understand health, food, and the planet. For more information on how Sequentia Biotech is using omics to generate impact, check out our blog: https://lnkd.in/eHx5yW8Y #Genomics #Bioinformatics #Omics #HealthTech #PublicHealth #R&D #Innovation #SequentiaBiotech
-
That’s a wrap on an unforgettable #ESCMIDGlobal2026! 🥨🎓 What an inspiring week in Munich! Connecting with academia, industry, and policymakers has reinforced why we do what we do. A massive thank you to everyone who attended our PROKY™ abstract presentation. The engagement and questions we received highlighted one thing: the transition from raw sequencing to actionable intelligence is the next frontier in infectious disease management. Beyond the abstract, it was a privilege to: - Showcase our full suite of omics solutions to researchers, hospitals and labs worldwide. - Discuss new strategies for identifying pathogen transmission routes using NGS. - Connect with 16,000+ peers dedicated to building a healthier future. Missed us between sessions? The conversation doesn't have to end here. Reach out to Riccardo Aiese Cigliano, Tiago Machado, or Guillermo Chumaceiro to learn more about how PROKY™ and our other platforms can support your mission. Until next year! 🤝 #ESCMIDGlobal #ClinicalMicrobiology #InfectiousDiseases #PROKY #Innovation #Munich2026 #PathogenTyping #Metagenomics #PublicHealth #Omics #Bioinformatics
-
-
“I want to analyze my own data, but I don’t know where to start.” 🧬 This is a common challenge in modern biology, where experimental data is increasingly computational. We are launching the Applied Bioinformatics Training Course: End-to-End RNA-seq Data Analysis (June 8–12, 09:00–14:00). This course is designed for PhD students and researchers who want to move from raw sequencing data to interpretable biological results through hands-on practice. Rather than focusing only on theory, we emphasize learning by doing, working through a complete RNA-seq analysis workflow. What you will work on: - Linux basics for bioinformatics workflows - R basics for biological data using RStudio and Bioconductor - Core concepts of RNA sequencing and experimental design - End-to-end RNA-seq analysis from raw data to results - Interpretation, quality control, and visualization 🛠️ 50% hands-on practice using real RNA-seq datasets 💻 100% online | ⏳ 25 hours | 👥 Small group format 📄 Attendance certificate included No prior advanced programming experience required. Recommended for molecular biology and life science backgrounds. 🎟️ 10% discount available for SIGA members. 🔗More information and enrollment details here: https://lnkd.in/eGuq5BBU #Bioinformatics #NGS #PhDLife #RNASeq #RStudio #Linux #Bioconductor
-
Live from #ESCMIDGlobal2026! 🔬 Science, Research, and Innovation in Action The energy at the Munich Messe is incredible! With five pillars of programming—from academic research to industry pipelines—the collaboration here is world-class. Our team is on the ground and ready to chat! We are officially presenting our abstract on PROKY™: A comprehensive bioinformatics pipeline for pathogen surveillance and genomic epidemiology Where to find us: Poster #P5288 ⬅️ While you're here to see the PROKY™ results, don't miss the chance to connect with our experts—Riccardo Aiese Cigliano (CSO), Tiago Machado (Sales Director), Giovanni Pacchiana (Business Development), and Guillermo Chumaceiro (Expert Bioinformatician). Whether your objective is the high-resolution reconstruction of transmission chains, implementing NGS-based diagnostics for key GI bacterial pathogens, or streamlining detection in complex samples, our team is ready to explore how our specialized pipelines deliver actionable insights. Stop us in the halls or join us at our presentation—let’s talk data! 🚀 #ESCMIDGlobal #ClinicalMicrobiology #InfectiousDiseases #PROKY #Innovation #Munich2026 #PathogenTyping #Metagenomics #PublicHealth #Omics #Bioinformatics #ScienceInAction
-
-
Granada is electric! Is your genomic analysis keeping pace? The V Congreso Interdisciplinar en Genética Humana is officially in session, and the energy at the Palacio de Congresos is incredible. Our Health Product Line Manager Erica Moran Martinez is on the ground and ready to help you bridge the gap between complex NGS data and real-world results. Whether you're attending sessions on New Diagnostic Technologies or Digital Health, come find us during the coffee breaks in the commercial area! Why stop for a chat during the coffee break? - Proprietary Solutions: We offer specialized bioinformatics environments for deep omic exploration. - Custom Pipelines: If your project has unique requirements, we develop bespoke features to fit your exact workflow. - Expert Support: We help labs move from raw reads to visualized reports using analytically validated pipelines. Don’t let your data sit idle. Stop by for a chat or a quick demo to see how our solutions can transform your output. 🚀 See you on the floor! 🤝 #CongresoGenética26 #AEGH #GINO #NGS #Bioinformatics #DigitalHealth
-
-
Stuck at the "data bottleneck"? 🧬 You’ve run your experiments, your NGS data is ready, but extracting meaningful insights requires computational skills that many life scientists were never formally trained in. We are launching the Applied Bioinformatics Training Course: End-to-End RNA-seq Data Analysis (June 8–12, 09:00–14:00). This 25-hour online course is designed to provide researchers with the practical foundations to run and interpret standard RNA-seq pipelines. What you will cover: - Linux basics for bioinformatics workflows - R basics for biological data using RStudio and Bioconductor - Core concepts of RNA sequencing and experimental design - End-to-end RNA-seq analysis from raw data to results - Interpretation, quality control, and visualization 💻 100% Online | ⏳ 25 Hours | 🛠️ 50% Hands-on Practice 👥 | Attendance Certificate Included 🎟️ 10% discount available for SIGA members. 🔗 More information and enrollment details here: https://lnkd.in/eGuq5BBU #Bioinformatics #NGS #PhDLife #RNASeq #RStudio #Linux #Bioconductor
-
MICK Clinical™: Built for Clinical Excellence and Now CE-IVDR Certified. 🧬🇪🇺 At Sequentia, we want to make microbiome genomics truly clinical. That is why we are officially launching MICK Clinical™, a software solution designed from its inception to meet the highest regulatory standards. Having achieved the CE-IVD mark under IVDR regulation, MICK Clinical™ enters the market as a fully compliant in vitro diagnostic medical device for gastrointestinal pathogen screening. With a validated sensitivity of 91.7% and specificity of 99.5% at the Vall d’Hebron University Hospital, this solution provides laboratories with the automated bioinformatics and clinical accuracy necessary for safe medical practice. From day one, MICK Clinical™ is here to bridge the gap between complex genomic data and reliable, reproducible results. 👇 Read the full story on: https://lnkd.in/eWvFZcBf #MedTech #IVDR #NGS #Microbiome #Diagnostics #SequentiaBiotech #ClinicalExcellence
-
Munich is calling! We’re heading to #ESCMIDGlobal2026. This year marks a major milestone for us as we join 16,000+ global experts to help shape the future of clinical microbiology. We aren't just attending—we are proud to contribute to the official scientific program with an abstract presentation featuring PROKY™. PROKY™ is our intuitive solution for the comprehensive analysis of bacterial sequencing data, specifically designed for outbreak investigations. It delivers the critical insights needed for prevention by rapidly identifying pathogen sources and transmission routes. Beyond our abstract, we’ll be showcasing our full ecosystem of omics solutions. We provide a complete analytical continuum: from basic taxonomical identification to high-resolution pathogen typing, transforming microbial genomics into actionable clinical insights. Our leadership and technical experts—Riccardo Aiese Cigliano (CSO), Tiago Machado (Sales Director), Giovanni Pacchiana (Business Development), and Guillermo Chumaceiro (Expert Bioinformatician)—will be on the ground to discuss how we are breaking the bioinformatics bottleneck. Ready to build a healthier tomorrow? Let’s connect in Munich! 🤝 See you in Munich! 🤝 #ESCMIDGlobal #ClinicalMicrobiology #InfectiousDiseases #PROKY #Innovation #Munich2026 #PathogenTyping #Metagenomics #PublicHealth #Omics #Bioinformatics
-